State Ledger
Company profile

BIOMARIN PHARMACEUTICAL INC CIK 1048477

Ticker
BMRN (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Novato, CA 94949
Fiscal year end
2025 (FY)
Market Data
Close
$55.41
Change
+$0.61
Change %
1.11%
Volume
103,889

BMRN · trading date Oct 12, 2026 · previous close $54.80 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
$3.22B
Net income
$348.90M
Total assets
$7.59B
Total liabilities
$1.51B
Stockholders' equity
$6.09B
Cash & equivalents
$1.31B
Operating income
$409.48M
Operating cash flow
$827.99M
Capital expenditures
$103.04M

Fiscal year 2025, via 10-K filed 2026-02-26. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
12.7%
Net margin
10.8%
Free cash flow
$724.96M
Free cash flow margin
22.5%
Liabilities / assets
19.8%
Equity / assets
80.2%
CapEx / revenue
3.2%
Operating cash flow / net income
2.37×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 $3.22B $348.90M $7.59B $1.51B $6.09B
2024 $2.85B $426.86M $6.99B $1.33B $5.66B
2023 $2.42B $167.65M $6.84B $1.89B $4.95B
2022 $2.10B $141.56M $6.38B $1.77B $4.60B
2021 $1.85B -$64.08M $6.00B $1.74B $4.27B
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 8-K
2026-09-15
Financials filed via
Form 10-K
filed 2026-02-26

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Novato, CA 94949
105 DIGITAL DRIVE
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:15 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to California — Public Companies